Understanding Your Breast Adenoma Diagnosis
At a Glance
A breast adenoma is a noncancerous growth made mainly of glandular tissue, not breast cancer. Biopsy identifies its type and checks for abnormal cells, while comparing the result with imaging helps guide whether monitoring, more testing, or removal is appropriate.
Finding a lump or receiving a biopsy result can be a frightening experience, often triggering immediate concerns about breast cancer. If you have been diagnosed with a breast adenoma, it is natural to feel a sense of relief that it is not cancer, yet remain confused about what this term actually means for your health.
A breast adenoma is a benign (non-cancerous) tumor made primarily of glandular or epithelial tissue [1]. Unlike cancer, typical benign adenomas do not invade nearby healthy tissue or spread to other parts of the body. While they may feel like a firm, movable lump, they are fundamentally different from malignant growths in how they behave and how they are treated.
Key Terms to Know
- Simple Benign Adenoma: A typical, non-cancerous overgrowth of glandular tissue (like a tubular adenoma).
- Atypia: Cells that look abnormal under a microscope. An adenoma without atypia is highly reassuring.
- Discordant Biopsy: When the benign tissue found in the biopsy does not fully explain the suspicious appearance seen on imaging.
- High-Risk Lesion: A separate finding on a biopsy that is not cancer, but requires close monitoring because it carries an increased risk of cancer developing in the future.
A Family of Tumors
It is important to understand that “breast adenoma” is not one single condition, but rather a family of different types of tumors [2]. The specific name of your adenoma often describes the type of cells involved or the life stage during which it appeared:
- Tubular Adenoma: These are most common in young women. They are composed of many small, tightly packed “tubules” or tube-like structures [1][3].
- Lactating Adenoma: These typically appear during the third trimester of pregnancy or while breastfeeding [4]. They are related to the hormonal changes that prepare the breasts for milk production and often shrink on their own after breastfeeding ends [4][5].
- Ductal Adenoma: A rarer type of adenoma that develops within the breast ducts [2].
- Nipple Adenoma: Also known as florid papillomatosis, these occur near the nipple and can sometimes cause discharge or skin changes [6].
Adenoma vs. Fibroadenoma
You may have heard of a more common benign lump called a fibroadenoma. While the names sound similar, they are distinct entities. Doctors distinguish them based on what the cells look like under a microscope:
- Fibroadenoma: This is a “biphasic” tumor, meaning it is made of both glandular tissue and stroma (the connective “support” tissue of the breast) [7]. In a fibroadenoma, the connective tissue is often the most prominent part [1].
- Adenoma: In a pure adenoma, the glandular or epithelial tissue dominates, with very little of the connective “stroma” seen in fibroadenomas [1][8].
On an ultrasound or mammogram, these two can look very similar. A biopsy is usually required to tell them apart with certainty [9].
Your Future Cancer Risk
One of the most common questions after a benign diagnosis is whether it increases the risk of developing breast cancer later. A pathologically confirmed simple adenoma, such as a tubular adenoma or lactating adenoma, does not usually increase your breast cancer risk on its own [3][4].
However, this does not mean your risk is zero. Your long-term risk still depends on your overall health, genetic history, and whether the biopsy identified any atypia (abnormal cell features) alongside the adenoma [10][11].
Management and Next Steps
Because typical adenomas are benign, the goal of care is focused on confirming the diagnosis and ensuring you are comfortable. There is no single “right” way to manage every adenoma; your plan will depend on your specific lesion and personal preferences.
- Radiologic-Pathologic Concordance: Your doctor will ensure that the biopsy results adequately explain what was seen on your imaging [9]. If a lump looked highly suspicious on an ultrasound but the biopsy only showed a simple adenoma, your team may recommend further testing to ensure the sample was representative of the whole area [12].
- Observation: If the adenoma is stable, not causing symptoms, and concordant, many doctors recommend simply monitoring it. The follow-up interval varies by local protocol and your individual risk [13].
- Removal: If the adenoma is growing, causing physical discomfort, lacks diagnostic certainty, or if you simply prefer it gone for peace of mind, you and your doctor may discuss removing it [13][14].
Common questions in this guide
What is a breast adenoma diagnosis?
What are the main types of breast adenoma?
Does a breast adenoma increase future breast cancer risk?
How is a breast adenoma different from a fibroadenoma?
What does it mean when a breast biopsy matches the imaging?
Does every breast adenoma need to be removed?
What does atypia mean on a breast adenoma biopsy?
Questions For You
Answer a question to get research tailored to you. Your answers are private.
Get notified when new evidence is published on breast adenoma.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.
Questions to Ask Your Doctor
Curated prompts to bring to your next appointment.
- 1.What specific subtype of adenoma (e.g., tubular, lactating, ductal) was identified in my biopsy?
- 2.Does my pathology report mention any 'atypia' or 'proliferative' features?
- 3.Is my biopsy result 'concordant' with what you saw on my imaging?
- 4.What follow-up imaging schedule do you recommend based on my specific lesion?
- 5.If this adenoma begins to grow or causes pain, what are my options for removal?
References
References (14)
- 1
Tubular Adenomas of the Breast Are Cytologically Distinct from Fibroadenomas.
Li JJX, Ng JKM, Lai BSW, et al.
Acta cytologica 2023; (67(3)):219-229 doi:10.1159/000527773.
PMID: 36516736 - 2
Nipple Adenoma: Clinicopathologic Characterization of 50 Cases.
Weigelt MA, Sciallis AP, McIntire PJ, et al.
The American journal of surgical pathology 2023; (47(8)):926-932 doi:10.1097/PAS.0000000000002063.
PMID: 37272622 - 3
Breast tubular adenoma: diagnostic challenges and management insights from a six-case series.
Ng WR, Pellegrino S, Macindoe C, et al.
Journal of surgical case reports 2026; (2026(9)):rjag865 doi:10.1093/jscr/rjag865.
PMID: 42813196 - 4
Imaging of Lactating Adenoma: Differential Diagnosis of Solid Mass Lesion in a Lactating Woman.
Ravikanth R, Kamalasekar K
Journal of medical ultrasound 2019; (27(4)):208-210 doi:10.4103/JMU.JMU_3_19.
PMID: 31867197 - 5
Breast lactating adenoma, an example of the utility of the radiological-pathological correlation.
Chico MJ, Causa Andrieu PI, Wernicke A, Pesce K
Clinical imaging 2021; (71()):136-140 doi:10.1016/j.clinimag.2020.11.009.
PMID: 33220595 - 6
Cryosurgery as a Minimally Invasive Alternative Treatment for a Patient with Erosive Adenomatosis of the Nipple.
Bae KN, Shin K, Kim WI, et al.
Annals of dermatology 2021; (33(2)):182-185 doi:10.5021/ad.2021.33.2.182.
PMID: 33935461 - 7
Postmenopausal Tubular Adenoma of the Breast: A Case Report.
Miles B, Zeinoddini A, Lahiji AP, et al.
Cureus 2022; (14(7)):e27076 doi:10.7759/cureus.27076.
PMID: 36000143 - 8
Giant tubular adenoma of the accessory breast in the anterior chest wall occurred in a pregnant woman.
Huang Y, Zhang H, Zhou Q, et al.
Diagnostic pathology 2015; (10()):60 doi:10.1186/s13000-015-0286-0.
PMID: 26040320 - 9
Mimickers of breast malignancy: imaging findings, pathologic concordance and clinical management.
Guirguis MS, Adrada B, Santiago L, et al.
Insights into imaging 2021; (12(1)):53 doi:10.1186/s13244-021-00991-x.
PMID: 33877461 - 10
Subsequent breast cancer risk after benign breast biopsy in racially diverse women: Siteman Cancer Center.
Koric A, Bennett DL, Boulos F, Colditz GA
Journal of the National Cancer Institute 2026; (118(7)):1229-1237 doi:10.1093/jnci/djag048.
PMID: 41697989 - 11
Subtypes of Benign Breast Disease as a Risk Factor of Breast Cancer: A Systematic Review and Meta Analyses.
Salamat F, Niakan B, Keshtkar A, et al.
Iranian journal of medical sciences 2018; (43(4)):355-364.
PMID: 30046203 - 12
Utilization of Percutaneous Needle Biopsy for Breast Diagnosis in a Comprehensive Breast Center: Implications for Development of Quality Indicators.
Holloway CM, Al-Riyees L, Saskin R
World journal of surgery 2016; (40(7)):1590-9 doi:10.1007/s00268-015-3293-0.
PMID: 26530690 - 13
American Society of Breast Surgeons and Society of Breast Imaging 2025 Guidelines for the Management of Benign Breast Fibroepithelial Lesions.
Rosenberger LH, White RL, Tafra L, et al.
JAMA surgery 2025; (160(12)):1378-1385 doi:10.1001/jamasurg.2025.4392.
PMID: 41123921 - 14
Select Choices in Benign Breast Disease: An Initiative of the American Society of Breast Surgeons for the American Board of Internal Medicine Choosing Wisely® Campaign.
Rao R, Ludwig K, Bailey L, et al.
Annals of surgical oncology 2018; (25(10)):2795-2800 doi:10.1245/s10434-018-6584-5.
PMID: 29968026
This page explains breast adenoma diagnoses and biopsy terms for informational purposes only and does not constitute medical advice. Your breast specialist and care team should interpret your imaging and pathology and recommend follow-up.